Although selective blockade of integrin αvβ8-mediated TGF-β activation has been shown to reverse tumor immunosuppression and enhance immune cell infiltration by modulating macrophage polarization, broader applications require caution (322). This evidence concerns the gene TGFB1 and neoplasm.